Preferred Label : adverse effects;

CISMeF synonym : Adverse Drug Reaction;

MeSH synonym : injurious effects; side effects; undesirable effects;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/c_2058872/fr/iqss-2020-ete-ortho-evenements-thrombo-emboliques-apres-pose-de-prothese-totale-de-hanche-hors-fracture-ou-de-genou
2026
false
false
false
France
arthroplasty, replacement, knee
arthroplasty, replacement, hip
quality indicators, health care
patient safety
deep vein thrombosis
pulmonary embolism
technical report
thromboembolism

---
https://ansm.sante.fr/informations-de-securite/oxbryta-voxelotor-suspension-de-lautorisation-de-mise-sur-le-marche-de-lunion-europeenne
https://ansm.sante.fr/actualites/oxbryta-voxelotor-conduite-a-tenir-suite-a-la-suspension-de-lautorisation-de-mise-sur-le-marche
2024
false
false
false
France
French
Safety-Based drug withdrawals
voxelotor
pharmacovigilance note
voxelotor
guidelines for drug use
drugs, investigational
france
europe
hematologic agents
Vaso-Occlusive Crisis

---
https://ansm.sante.fr/actualites/reevaluation-europeenne-de-la-balance-benefice-risque-des-medicaments-contenant-du-finasteride-ou-du-dutasteride
2024
false
false
false
France
French
drug information
finasteride
Dutasteride
product surveillance, postmarketing
pharmacovigilance

---
https://www.cbip.be/fr/articles/4417?folia=4409
2024
false
false
false
Belgium
French
journal article
drug information
vitamin B 6
vitamin B 6
nervous system diseases
Iatrogenic neuropathy (disorder)
Long-term current use of drug therapy (situation)
vitamin B 6

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2024
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel

---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections
risk

---
https://ansm.sante.fr/tableau-marr/lomitapide
2024
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)

---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines

---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases

---
https://ansm.sante.fr/informations-de-securite/adagrasib-risque-potentiel-deffets-indesirables-cutanes-severes
2024
false
false
false
France
French
pharmacovigilance note
risk
adagrasib
stevens-johnson syndrome
epidermal necrolysis, toxic
adagrasib
antineoplastic agents
Adagrasib Regimen

---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections

---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
2024
false
false
false
France
French
risk management
valproic acid
Male
Neurodevelopmental Disorders
Chimeric antigen receptor T-cell therapy
genetic therapy
Secondary Carcinoma
Chimeric Antigen Receptor Therapy
immunotherapy, adoptive
pharmacovigilance note

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy
drug prescriptions

---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2024
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording

---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child

---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2024
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms

---
https://ansm.sante.fr/tableau-marr/rituximab-3
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Rituximab
Rituximab
risk management
continuity of patient care
child
infusions, intravenous
leukoencephalopathy, progressive multifocal
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/ravulizumab
2024
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized

---
https://ansm.sante.fr/tableau-marr/cemiplimab
2024
false
false
false
France
French
risk management
patients guideline
cemiplimab
Antineoplastic Agents, Immunological
infusions, intravenous
cemiplimab
drug monitoring
lymphohistiocytosis, hemophagocytic

---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2024
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
Safety-Based drug withdrawals

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-marr/fenfluramine
2024
false
false
false
France
French
administration, oral
risk management
guidelines for drug use
pharmacovigilance note
fenfluramine
fenfluramine
continuity of patient care
drug monitoring
hypertension, pulmonary
Drug-Related side effects and adverse reactions
heart valve diseases
patients guideline
Off-Label use

---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/fingolimod
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management

---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)

---
https://ansm.sante.fr/tableau-marr/eculizumab
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
Drug-Related side effects and adverse reactions
meningococcal vaccines

---
https://ansm.sante.fr/tableau-marr/etonogestrel
2024
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins

---
http://publications.msss.gouv.qc.ca/msss/document-001040/
2024
false
true
false
Canada
immunization schedule
vaccines
measles-mumps-rubella vaccine
meningococcal vaccines
pneumococcal vaccines
influenza vaccines
Diphtheria-Tetanus-Pertussis vaccine
rotavirus vaccines
child
infant
popular works
vaccination

---
http://publications.msss.gouv.qc.ca/msss/document-000454/
2024
false
true
false
Canada
measles
measles
measles vaccine
popular works
measles vaccine

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2024
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/acitretine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/alitretinoine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
Drug-Related side effects and adverse reactions
Alitretinoin
Alitretinoin

---
https://ansm.sante.fr/tableau-marr/emicizumab
2024
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
emicizumab
continuity of patient care
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/isotretinoine
2024
false
false
false
France
French
administration, oral
isotretinoin
risk management
acne vulgaris
isotretinoin
teratogens
pregnancy
contraception
mental disorders
dyslipidemias
Chemical and Drug Induced Liver Injury
patient education handout
forms
pancreatitis
guidelines for drug use
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/rituximab
2024
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://ansm.sante.fr/tableau-marr/vandetanib
2024
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
RET Gene Mutation
guidelines for drug use
piperidines
quinazolines
piperidines
quinazolines

---
https://sfsep.org/sep-et-vaccinations/
2024
true
false
false
false
France
guidelines as topic
professional practice
patient care management
drug interactions
Immunosuppression Therapy
guideline
multiple sclerosis
multiple sclerosis
multiple sclerosis, nos
vaccination, nos
preventive immunization/medication
vaccination
Multiple sclerosis
multiple sclerosis

---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-dernieres-donnees-confirment-de-nouveau-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus infections
vaccination
papillomavirus vaccines
papillomavirus vaccines
drug information
pharmacovigilance
safety management
patient safety
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)

---
https://www.cbip.be/fr/articles/4425?folia=4409
2024
false
false
false
Belgium
French
risk
journal article
pharmacovigilance note
pulmonary disease, chronic obstructive
Chronic obstructive pulmonary disease exacerbation
Gabapentin
Pregabalin
cohort studies

---
https://www.cochrane.org/fr/CD007693/ORAL_fluorure-topique-comme-cause-de-la-fluorose-dentaire-chez-lenfant
2024
false
United Kingdom
France
French
meta-analysis
fluorosis, dental
fluorides, topical
child
french abstract

---
https://www.cochrane.org/fr/CD008879/COLOCA_une-alimentation-complementaire-avant-loperation-est-elle-preferable-une-alimentation-normale-chez
2024
false
France
United Kingdom
French
french abstract
meta-analysis
digestive system surgical procedures
preoperative care
dietary supplements
treatment outcome
enteral nutrition
parenteral nutrition
postoperative complications

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations

---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://www.cbip.be/fr/articles/4263?folia=4259
2024
false
false
false
Belgium
French
journal article
drug information
glucocorticoids
administration, oral
Long-term current use of drug therapy (situation)

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://ansm.sante.fr/actualites/enceinte-les-medicaments-cest-toujours-pas-nimporte-comment
2024
false
false
false
France
French
drug information
pregnancy
pregnant women
pharmaceutical preparations
abnormalities, drug-induced

---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiomes-intracraniens-le-bmj-publie-une-etude-epidemiologique-francaise
2024
false
false
false
France
French
pharmacovigilance note
epidemiologic studies
france
meningioma
meningioma
medroxyprogesterone acetate
risk assessment
Product containing only levonorgestrel in intrauterine dose form (medicinal product form)
levonorgestrel
injections, intramuscular
plastic iud with progestogen
administration, intravaginal
progestins
intrauterine devices
medroxyprogesterone

---
https://www.cbip.be/fr/articles/4284?folia=4275
2024
false
false
false
Belgium
French
Dutch
journal article
pseudoephedrine
belgium
europe

---
https://ansm.sante.fr/informations-de-securite/en-cas-de-rhume-ne-pas-utiliser-de-medicaments-a-base-de-pseudoephedrine-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
pseudoephedrine
administration, oral
pharmacovigilance note
nasal decongestants
common cold
risk factors
risk
pseudoephedrine
pseudoephedrine, combinations
guidelines

---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents

---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording

---
https://ansm.sante.fr/tableau-marr/natalizumab-1
2024
false
false
false
France
French
Natalizumab
risk management
Natalizumab
natalizumab
guidelines for drug use
patient education handout
continuity of patient care
Drug-Related side effects and adverse reactions
opportunistic infections
leukoencephalopathy, progressive multifocal
immunologic factors
immunologic factors
multiple sclerosis

---
https://www.cbip.be/fr/articles/4316?folia=4305
2024
false
false
false
Belgium
French
journal article
Selective Serotonin Reuptake Inhibitors
risk
gastrointestinal hemorrhage

---
https://www.cbip.be/fr/articles/4328?folia=4319
2024
false
false
false
Belgium
French
journal article
valproic acid
risk management
Exposure to anticonvulsant (event)
paternal exposure
Neurodevelopmental Disorders
child

---
https://ansm.sante.fr/actualites/sante-des-enfants-nes-apres-assistance-medicale-a-la-procreation-pas-daugmentation-globale-du-risque-de-cancer-mais-une-legere-augmentation-du-risque-de-leucemie-nest-pas-exclue
2024
false
false
false
France
French
vigilance note
reproductive techniques, assisted

---
http://beh.santepubliquefrance.fr/beh/2024/9/2024_9_2.html
2024
false
false
false
France
alcoholic beverages
consumer health information
journal article
alcohol drinking

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mai-2024-13-16-mai
2024
false
false
false
France
French
drug information
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
europe

---
https://www.cbip.be/fr/articles/4320?folia=4319
2024
false
false
false
Belgium
French
patient safety
acetaminophen
pregnancy trimester, third
journal article
fetus
In Utero Drug Exposure
infant, newborn
Premature Closure of Ductus Arteriosus

---
https://www.cbip.be/fr/articles/4344?folia=4336
2024
false
false
false
Belgium
French
journal article
pharmacovigilance note
Denosumab
hypocalcemia
denosumab
renal insufficiency

---
https://ansm.sante.fr/tableau-marr/velmanase-alfa
2024
false
false
false
France
French
risk management
continuity of patient care
Drug-Related side effects and adverse reactions
guidelines for drug use
velmanase alfa
Velmanase Alfa
infusions, intravenous
enzyme replacement therapy
drug hypersensitivity
home infusion therapy
medication errors
Velmanase Alfa
anaphylaxis
Infusion-Related Reaction

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-juin-2024-10-13-juin
2024
false
false
false
France
French
pharmacovigilance note
risk assessment
risk
dipyrone
agranulocytosis
gene therapy
Chimeric Antigen Receptor T-cells
Antineoplastic Agents, Immunological
Therapy-Associated cancer
Chimeric Antigen Receptor Therapy

---
https://ansm.sante.fr/tableau-marr/zilucoplan
2024
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines

---
https://www.cbip.be/fr/articles/4345?folia=4336
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
mianserin
mianserin
Compulsive Sexual Behavior Disorder
antidepressive agents, second-generation
aged

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiome-renforcement-des-conditions-de-prescription-et-de-delivrance-de-depo-provera-150-mg-3-ml-et-colprone-5-mg
2024
false
false
false
France
French
guidelines for drug use
meningioma
risk management
legislation, drug
medroxyprogesterone acetate
Drug-Related side effects and adverse reactions
medrogestone
progesterone congeners
medrogestone
medroxyprogesterone

---
https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-medroxyprogesterone-depo-provera-150-mg-3-ml-et-de-medrogestone-colprone-5-mg-liees-au-risque-de-meningiome-a-compter-du-1er-juillet-2024
2024
false
false
false
France
French
guidelines for drug use
meningioma
risk management
legislation, drug
medroxyprogesterone acetate
Drug-Related side effects and adverse reactions
medrogestone
progesterone congeners
medrogestone
medroxyprogesterone
drug prescriptions
Renewal of prescription (procedure)
professional role
physicians
pharmacists
summary of product characteristics
package leaflet

---
https://ansm.sante.fr/actualites/analogues-du-glp-1-point-sur-la-surveillance-des-effets-indesirables-graves-et-mesusages
2024
false
false
false
France
French
pharmacovigilance note
Glucagon-Like Peptide-1 Receptor Agonists
Serious Adverse Drug Reaction
product surveillance, postmarketing
pharmacovigilance
Drug Misuse

---
https://ansm.sante.fr/tableau-marr/acetate-de-nomegestrol
2024
false
false
false
France
French
drug information
risk management
nomegestrol acetate
nomegestrol
progesterone congeners
administration, oral
risk
meningioma
continuity of patient care
patients guideline

---
https://ansm.sante.fr/tableau-marr/acetate-de-chlormadinone
2024
false
true
false
France
French
risk management
meningioma
chlormadinone acetate
progesterone congeners
chlormadinone
drug information
patients guideline
continuity of patient care
mass screening
meningioma
risk

---
https://ansm.sante.fr/tableau-marr/medrogestone
2024
false
false
false
France
French
risk management
medrogestone
administration, oral
medrogestone
risk
meningioma
continuity of patient care
progesterone congeners
patients guideline
drug information
meningioma

---
https://ansm.sante.fr/tableau-marr/acetate-de-medroxyprogesterone
2024
false
false
false
France
French
risk management
medroxyprogesterone acetate
risk
meningioma
meningioma
injections, intramuscular
medroxyprogesterone
continuity of patient care
drug information
patients guideline
progesterone congeners
contraceptive agents, female

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-juillet-2024-8-11-juillet
2024
false
false
false
France
French
pharmacovigilance note
europe
Glatiramer Acetate
Glucagon-Like Peptide-1 Receptor Agonists
risk management
anesthesia, general
deep sedation
Aspiration Pneumonitis
anaphylaxis

---
https://ansm.sante.fr/actualites/ballons-gastriques-allurion-recommandations-pour-limiter-la-survenue-de-complications-graves
2024
false
false
false
France
French
equipment and supplies note
gastric balloon
continuity of patient care
Insertion of gastric balloon (procedure)
guideline
patients guideline
intestinal obstruction
Acquired obstruction of pylorus (disorder)
Pyloric Obstruction
Gastric Perforation
risk
risk management

---
https://www.cbip.be/fr/articles/4380?folia=4379
2024
false
false
false
Belgium
French
journal article
drug information
europe
drug approval
lecanemab
alzheimer disease
risk
lecanemab
lecanemab

---
https://ansm.sante.fr/actualites/lansm-suspend-les-ballons-gastriques-allurion
2024
false
false
false
France
French
equipment and supplies note
guideline
gastric balloon
Safety-Based medical device withdrawals
france

---
https://ansm.sante.fr/dossiers-thematiques/topiramate-et-grossesse
2024
false
false
false
France
French
Topiramate
pregnancy
patients guideline
epilepsy
migraine disorders
Topiramate
guideline
risk
abnormalities, drug-induced
In Utero Drug Exposure
Female of Childbearing Potential
topiramate

---
https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy

---
https://ansm.sante.fr/informations-de-securite/acetate-de-glatiramere-des-reactions-anaphylactiques-peuvent-survenir-des-mois-voire-des-annees-apres-linstauration-du-traitement
2024
false
false
false
France
French
pharmacovigilance note
Glatiramer Acetate
glatiramer acetate
adjuvants, immunologic
anaphylaxis
Anaphylactic Reaction
injections, subcutaneous
multiple sclerosis, relapsing-remitting

---
https://ansm.sante.fr/actualites/lautorisation-de-mise-sur-le-marche-du-medicament-progesterone-retard-pharlon-caproate-dhydroxyprogesterone-est-suspendue
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure

---
https://ansm.sante.fr/informations-de-securite/suspension-des-autorisations-de-mise-sur-le-marche-des-medicaments-contenant-du-caproate-dhydroxyprogesterone
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure
guideline

---
https://ansm.sante.fr/informations-de-securite/crayon-au-nitrate-dargent-restriction-des-indications-et-rappel-des-risques
2024
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
silver nitrate
silver nitrate
risk

---
https://ansm.sante.fr/actualites/pronostic-a-18-mois-des-cas-de-myocardite-attribuables-a-la-vaccination-arnm-contre-le-covid-19-le-jama-publie-les-resultats-dune-etude-de-pharmaco-epidemiologie-realisee-par-epi-phare
2024
false
false
false
France
French
drug information
COVID-19 Vaccines
mRNA Vaccines
myocarditis
myocarditis
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
prognosis
france
covid-19, RNA-based vaccine
COVID-19
mRNA COVID-19 Vaccine
cohort studies

---
https://ansm.sante.fr/tableau-marr/voriconazole
2024
false
false
false
France
French
risk management
Voriconazole
antifungal agents
drug information
patients guideline
dermatitis, phototoxic
dermatitis, phototoxic
risk
skin neoplasms
skin neoplasms
Skin Squamous Cell Carcinoma
Skin Squamous Cell Carcinoma
voriconazole

---
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/aout-2024.html#a2_a1
2024
false
false
false
Canada
French
pregnancy
pregnant women
pharmacovigilance note
calcium carbonate
antacids
Milk-Alkali syndrome
risk
gastroesophageal reflux
calcium carbonate

---
https://ansm.sante.fr/tableau-marr/mavacantem
2024
false
false
false
France
French
risk management
mavacamten
mavacamten
mavacamten
administration, oral
patients guideline
guidelines for drug use
fetus
pregnancy
embryo
drug interactions
heart failure, systolic
Fetal exposure to drug (situation)
Cytochrome P-450 CYP2C19 Inhibitors
Cytochrome P-450 CYP3A4 Inhibitors
Cytochrome P450 family 2 subfamily C member 19 intermediate metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 ultra-rapid metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 normal metabolizer (finding)

---
https://www.afsos.org/wp-content/uploads/2024/09/AFSOS-referentiel-NVAI_0824.pdf
2024
false
false
false
France
antineoplastic agents
chemotherapy-induced nausea and vomiting
antiemetics
algorithms
nausea
guideline

---
https://ansm.sante.fr/tableau-marr/ranibizumab-3
2024
false
false
false
France
French
risk management
Ranibizumab
package leaflet
patient education handout
drug information
Ranibizumab

---
https://www.cbip.be/fr/articles/4404?folia=4395
2024
false
false
false
Belgium
French
proton pump inhibitors
infant
child
journal article
drug information
serious infection
Infections

---
https://ansm.sante.fr/tableau-marr/brigatinib
2024
false
false
false
France
French
risk management
brigatinib
patients guideline
patient education handout
drug information
Pneumonitis
Interstitial lung disease (disorder)
brigatinib
administration, oral
antineoplastic agents
protein kinase inhibitors

---
https://ansm.sante.fr/tableau-marr/trastuzumab-deruxtecan
2024
false
false
false
France
French
risk management
trastuzumab deruxtecan
trastuzumab deruxtecan
infusions, intravenous
Antineoplastic Agents, Immunological
medication errors
guidelines for drug use
lung diseases
patient education handout
patients guideline
trastuzumab deruxtecan
Antineoplastic Agents, Immunological

---
https://ansm.sante.fr/tableau-marr/tebentafusp
2024
false
false
false
France
French
patients guideline
guidelines for drug use
drug information
risk management
tebentafusp
tebentafusp
infusions, intravenous
Cytokine Release Syndrome
signs and symptoms
antineoplastic agents

---
https://ansm.sante.fr/actualites/tramadol-et-codeine-devront-etre-prescrits-sur-une-ordonnance-securisee-des-le-1er-decembre
https://ansm.sante.fr/actualites/decision-du-24-09-2024-portant-application-dune-partie-de-la-reglementation-des-stupefiants-et-fixant-des-durees-de-prescription-tramadol-codeine
2024
false
false
false
France
French
patients guideline
guidelines for drug use
tramadol
codeine
drug prescriptions
legislation, pharmacy
prescription drug diversion
prescription drug misuse
opioid-related disorders
risk
risk management
analgesics, opioid
dihydrocodeine
Duration of Therapy

---
https://www.cbip.be/fr/articles/4407?folia=4395
2024
false
false
false
Belgium
French
minoxidil
administration, cutaneous
child
hypertrichosis
drug information
journal article
risk

---
https://ansm.sante.fr/actualites/prevention-de-la-bronchiolite-du-nourrisson-les-premieres-donnees-de-pharmacovigilance-confirment-le-profil-de-securite-du-nirsevimab-beyfortus
2024
false
false
false
France
French
bronchiolitis, viral
infant, newborn
infant
pharmacovigilance
respiratory syncytial virus infections
nirsevimab
nirsevimab
risks and benefits
Benefit-Risk assessment
hospitalization
investigative report
drug information
technical report
nirsevimab

---
https://www.cbip.be/fr/articles/4410?folia=4409
2024
false
false
false
Belgium
French
pregnancy
hypoglycemic agents
drug information
journal article
diabetes mellitus, type 2
hypoglycemic agents
risk assessment
congenital abnormalities
Maternal Preconception Stage
practice guidelines as topic
belgium
insulin
metformin
administration, oral
injections, subcutaneous

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2023-6-9-fevrier
2023
false
false
false
France
French
drug information
risk assessment
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
vasoconstrictor agents
administration, oral

---
PUBLIÉ LE 27/02/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/informations-de-securite/zolgensma-onasemnogene-abeparvovec-cas-dinsuffisance-hepatique-aigue-dissue-fatale
2023
false
false
false
France
French
pharmacovigilance note
risk
onasemnogene abeparvovec-xioi
Onasemnogene Abeparvovec
onasemnogene abeparvovec
liver function tests
continuity of patient care
Monitoring of liver function (regime/therapy)
liver failure, acute
child
infant
liver failure, acute
guidelines for drug use

---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma

---
https://ansm.sante.fr/tableau-marr/ranibizumab-1
2023
false
false
false
France
French
risk management
patient education handout
Ranibizumab
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
intravitreal injections

---
https://www.cbip.be/fr/articles/4045?folia=4031
2023
false
false
false
Belgium
French
journal article
proton pump inhibitors

---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation

---
https://ansm.sante.fr/tableau-marr/tofacitinib
2023
false
false
false
France
French
risk management
tofacitinib
tofacitinib
continuity of patient care
checklist
guidelines for drug use
patient education handout
Janus Kinase Inhibitors
tofacitinib
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
pregnancy
teratogens
Virus Reactivation
tuberculosis
neoplasms
embolism and thrombosis
herpes zoster

---
https://ansm.sante.fr/actualites/epi-phare-publie-dans-le-nejm-les-resultats-dune-etude-qui-montre-quil-ny-a-pas-daugmentation-du-risque-devenement-cardiovasculaire-grave-avec-les-vaccins-bivalents-contre-le-covid-19
2023
false
false
false
France
French
drug information
COVID-19 Vaccines
Bivalent Vaccines
mRNA Vaccines
cardiovascular diseases

---
PUBLIÉ LE 31/03/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-10-02-2023-au-16-03-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib

---
https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants
2023
false
false
false
France
French
guidelines for drug use
patient education handout
mydriatics
ophthalmic solutions
child

---
https://ansm.sante.fr/actualites/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance
2023
false
false
false
France
French
abnormalities, drug-induced
teratogens
pharmacovigilance note
pregnancy
hydroxychloroquine
risk
patient education handout
In Utero Drug Exposure
antirheumatic agents

---
https://ansm.sante.fr/informations-de-securite/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
https://ansm.sante.fr/actualites/inhibiteurs-de-janus-kinase-et-traitement-des-maladies-inflammatoires-chroniques-restrictions-dutilisation-pour-diminuer-le-risque-deffets-indesirables-graves
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Janus Kinase Inhibitors
Chronic inflammatory disorder (disorder)
chronic disease

---
https://publications.msss.gouv.qc.ca/msss/document-003568/
2023
false
false
false
Canada
noise
guideline
noise

---
https://ansm.sante.fr/dossiers-thematiques/acne-severe-et-traitement-par-isotretinoine
2023
false
false
false
France
French
video recording
popular works
isotretinoin
administration, oral
isotretinoin
pregnancy
isotretinoin
teratogens
acne vulgaris

---
https://www.cbip.be/fr/articles/4070?folia=4050
2023
false
false
false
Belgium
French
anticonvulsants
teratogens
pregnancy
journal article

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-16-03-2023-au-13-04-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/tableau-marr/filgotinib
2023
false
false
false
France
French
guidelines for drug use
risk management
filgotinib
administration, oral
patient education handout
filgotinib
filgotinib
Janus Kinase Inhibitors
adult
aged
pregnancy
breast feeding
Janus Kinase Inhibitors
arthritis, rheumatoid

---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2023
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain

---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2023
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy

---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2023
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel

---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/tableau-marr/citrate-de-cafeine
2023
false
false
false
France
French
pharmacovigilance note
caffeine citrate
guidelines for drug use
infant, newborn
infusions, intravenous
infant, premature
caffeine citrate
sleep apnea, newborn, primary
Primary apnea in the newborn (finding)
sleep apnea, central
caffeine
citrates
caffeine
citrates

---
https://ansm.sante.fr/tableau-marr/chlorhydrate-de-mexiletine
2023
false
false
false
France
French
pharmacovigilance note
mexiletine hydrochloride
guidelines for drug use
risk management
mexiletine hydrochloride
arrhythmias, cardiac
hepatic insufficiency
mexiletine hydrochloride
patient education handout
Drug-Related side effects and adverse reactions
risk
continuity of patient care
mexiletine
mexiletine
mexiletine

---
https://ansm.sante.fr/tableau-marr/esketamine
2023
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine

---
https://ansm.sante.fr/tableau-marr/baclofene
2023
false
false
false
France
French
baclofen
baclofen
risk management
guidelines for drug use
patients guideline
patient education handout
continuity of patient care
drug monitoring
alcoholism

---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol

---
https://www.medsubhyp.fr/recommandations-en-sante-au-travail/
2023
false
false
false
France
French
consensus
adolescent
adult
pregnancy
hematologic diseases
cardiovascular diseases
respiratory tract diseases
eye diseases
skin diseases
tooth diseases
kidney diseases
gastrointestinal diseases
musculoskeletal diseases
otorhinolaryngologic diseases
occupational medicine
occupational medicine
occupational health physicians
return to work
government regulation
signs and symptoms
aged
hearing tests
respiratory function tests
risk assessment
accidents
barotrauma
barotrauma
occupational exposure
central nervous system diseases
occupational medicine
submarine medicine
mental disorders
work capacity evaluation

---
https://ansm.sante.fr/tableau-marr/alemtuzumab
2023
false
false
false
France
French
risk management
Alemtuzumab
Alemtuzumab
alemtuzumab
infusions, intravenous
continuity of patient care
multiple sclerosis, relapsing-remitting
guidelines for drug use
patients guideline
patient education as topic
Drug-Related side effects and adverse reactions
drug monitoring
clinical chemistry tests
thyroid diseases
purpura, thrombocytopenic, idiopathic
kidney diseases
anti-glomerular basement membrane disease
Infections
pregnancy
mass screening
Contraindications, Drug
premedication

---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2023
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2023
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2023
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://www.ansm.sante.fr/actualites/anti-inflammatoires-non-steroidiens-ains-et-complications-infectieuses-graves
2023
false
false
false
France
French
pharmacovigilance note
anti-inflammatory agents, non-steroidal
Infections
fever
pain
ibuprofen
ketoprofen
adult
child
streptococcal infections
guidelines for drug use

---
https://www.cbip.be/fr/articles/4075?folia=4050
2023
false
false
false
Belgium
French
journal article
administration, oral
ivermectin
ivermectin
antiparasitic agents
drug eruptions
epidermal necrolysis, toxic
stevens-johnson syndrome
pharmacovigilance note

---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound

---
https://www.cbip.be/fr/articles/4090?folia=4079
2023
false
false
false
Belgium
French
lactation disorders
journal article
pharmaceutical preparations
Drug-Related side effects and adverse reactions
breast feeding

---
https://ansm.sante.fr/actualites/evaluation-europeenne-du-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-par-valproate-dans-les-mois-precedant-la-conception
2023
false
false
false
France
French
Neurodevelopmental Disorders
valproate
fathers
paternal exposure
valproic acid
risk assessment
comparative study
drug information
valproic acid
anticonvulsants
europe
Neurodevelopmental Disorders
child

---
https://www.cbip.be/fr/articles/4084?folia=4079
2023
false
false
false
Belgium
French
journal article
sodium
pharmaceutic aids
cardiovascular diseases

---
https://ansm.sante.fr/actualites/acidose-lactique-et-metformine-un-risque-evitable
2023
false
false
false
France
French
risk management
metformin
acidosis, lactic
Drug-Related side effects and adverse reactions
acidosis, lactic
pharmacovigilance note
guidelines for drug use
patients guideline
renal insufficiency
risk factors
continuity of patient care
hypoglycemic agents
Renal function monitoring (regime/therapy)

---
PUBLIÉ LE 17/05/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-04-2023-au-11-05-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/4098?folia=4095
2023
false
false
false
Belgium
French
journal article
Immunosuppression Therapy
immunosuppressive agents
neoplasms
graft rejection
organ transplantation
risk
risk assessment
neoplasms

---
https://ansm.sante.fr/informations-de-securite/gavreto-pralsetinib-augmentation-du-risque-de-tuberculose-et-mesures-de-reduction-du-risque-associees
2023
false
false
false
France
French
pharmacovigilance note
risk
tuberculosis
pralsetinib
pralsetinib

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.has-sante.fr/jcms/p_3445860/fr/flash-securite-patient-les-soins-en-ville-les-risques-existent-aussi
2023
false
false
false
France
therapeutics
guideline
urban health services

---
https://www.infectiologie.com/fr/actualites/position-de-la-spilf-sur-les-effets-indesirables-des-fluoroquinolones_-n.html
2023
false
false
false
France
scientific and technical information
fluoroquinolones

---
https://ansm.sante.fr/actualites/progestatifs-et-meningiome-pas-daugmentation-du-risque-avec-les-diu-au-levonorgestrel-mais-confirmation-du-risque-pour-3-nouvelles-substances
2023
false
false
false
France
French
technical report
pharmacovigilance note
meningioma
risk assessment
meningioma
intrauterine devices, medicated
levonorgestrel
progestins
promegestone
medrogestone
administration, oral
medroxyprogesterone acetate
injections, intramuscular
administration, intravaginal
retrospective studies

---
https://ansm.sante.fr/informations-de-securite/clomid-50-mg-comprime-risque-de-troubles-visuels-graves-cecite
2023
false
false
false
France
French
blindness
pharmacovigilance note
risk
clomiphene
vision disorders
clomiphene citrate
clomifene
optic neuritis
optic neuropathy, ischemic
retinal vein occlusion
Central Retinal Vein Occlusion
retinal detachment
vitreous detachment

---
https://ansm.sante.fr/actualites/clomid-citrate-de-clomifene-le-traitement-doit-etre-arrete-en-cas-dalteration-de-la-vision
2023
false
false
false
France
French
guidelines for drug use
clomiphene
vision disorders
pharmacovigilance note
clomiphene citrate
fertility agents, female
clomifene

---
https://ansm.sante.fr/actualites/lamotrigine-attention-au-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
Lamotrigine
lamotrigine
drug eruptions
administration, oral
anticonvulsants
antipsychotic agents
drug hypersensitivity syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
guidelines for drug use

---
https://www.anses.fr/fr/content/complements-alimentaires-plantes-meilleure-information-des-consommateurs
2023
false
false
false
France
French
phytotherapy
herb-drug interactions
plants, medicinal
scientific and technical information
drug information
guidelines
plants, medicinal
dietary supplements

---
https://ansm.sante.fr/actualites/traitement-de-lacne-severe-mieux-faire-connaitre-les-risques-associes-a-lisotretinoine-orale
2023
false
false
false
France
French
isotretinoin
administration, oral
acne vulgaris
teratogens
pregnancy
mental disorders
drug information
isotretinoin
video recording

---
https://ansm.sante.fr/tableau-marr/anakinra
2023
false
false
false
France
French
risk management
anakinra
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/informations-de-securite/valproate-et-derives-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-dans-les-3-mois-qui-precedent-la-conception
2023
false
false
false
France
French
pharmacovigilance note
Divalproex Sodium
Neurodevelopmental Disorders
Male
risk
risk assessment
fathers
infant
child
Perinatal Exposure
paternal exposure
valproic acid
valproate sodium
teratogens

---
https://ansm.sante.fr/informations-de-securite/antibiotiques-de-la-famille-des-fluoroquinolones-administres-par-voie-systemique-ou-inhalee-rappel-des-restrictions-dutilisation
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
fluoroquinolones
administration, oral
administration, inhalation
injections
Off-Label use

---
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/juillet-2023.html#a3.1.1
2023
false
false
false
Canada
French
English
COVID-19 Vaccines
mRNA Vaccines
menorrhagia
vaccination
canada
drug information

---
https://ansm.sante.fr/informations-de-securite/ketamine-une-utilisation-prolongee-entraine-des-atteintes-graves-hepatiques-et-uronephrologiques
2023
false
false
false
France
French
pharmacovigilance note
ketamine
kidney diseases
Drug-Induced Liver Disease
cystitis
narcotics
prescription drug misuse
guidelines for drug use
Long-Term
Off-Label use
biliary tract diseases

---
https://ansm.sante.fr/actualites/lansm-rappelle-le-bon-usage-de-la-ketamine
2023
false
false
false
France
French
ketamine
ketamine
guidelines for drug use
analgesics
analgesics
analgesics
ketamine
pain, intractable
chronic pain
biliary tract diseases
kidney diseases
urologic diseases
Drug-Induced Liver Disease
continuity of patient care
patient education handout
Off-Label use
prescription drug misuse
narcotics

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-14-04-2023-au-8-06-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
Domperidone and psychiatric withdrawal events when used off-label for lactation stimulation
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/aout-2023.html#a3-1-1
2023
false
false
false
Canada
French
English
pharmacovigilance note
domperidone
Off-Label use
substance withdrawal syndrome
Lactation stimulation therapy

---
Wearable Respiratory Sensor for the Detection of Opioid-Induced Respiratory Depression
https://www.cadth.ca/fr/un-capteur-portable-pour-detecter-la-depression-respiratoire-causee-par-un-opioide
2023
false
false
false
Canada
French
English
health technology assessment
respiratory depression
opioids
Wearable Electronic Devices

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://ansm.sante.fr/actualites/deodorant-nuud-retrait-du-marche-par-le-fabricant-de-lensemble-des-lots-de-ce-deodorant
2023
false
false
false
France
French
deodorants
vigilance note
epidermal cyst
epidermal cyst
superinfection

---
https://ansm.sante.fr/dossiers-thematiques/campagne-de-vaccination-au-college
2023
false
false
false
France
French
mass vaccination
vaccination
schools
guideline
papillomavirus vaccines
drug surveillance, postmarketing
continuity of patient care
adverse drug reaction reporting systems
Drug-Related side effects and adverse reactions

---
https://www.has-sante.fr/jcms/p_3459828/fr/chlormadinone-viatris-acetate-de-chlormadinone-gynecologie
2023
false
false
false
France
chlormadinone acetate
treatment outcome
insurance, health, reimbursement
risk assessment
chlormadinone
meningioma
premenopause
progesterone
hormone replacement therapy
menstruation disturbances
mastodynia
endometriosis
evaluation of the transparency committee
chlormadinone acetate

---
https://www.has-sante.fr/jcms/p_3459822/fr/lutenyl-acetate-de-nomegestrol-gynecologie
2023
false
false
false
France
nomegestrol acetate
risk assessment
treatment outcome
meningioma
nomegestrol
premenopause
hormone replacement therapy
menstruation disturbances
menopause
progesterone
evaluation of the transparency committee
nomegestrol acetate

---
https://ansm.sante.fr/actualites/topiramate-epitomax-et-generiques-et-troubles-neurodeveloppementaux-mise-en-place-de-mesures-en-europe-pour-limiter-lutilisation-pendant-la-grossesse
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Topiramate
pregnancy
europe
Neurodevelopmental Disorders
risk
risk management
drug evaluation
Topiramate
france
anticonvulsants
anticonvulsants
anticonvulsants
Topiramate
topiramate
Female of Childbearing Potential

---
https://www.cbip.be/fr/articles/4164?folia=4158
2023
false
false
false
Belgium
French
journal article
risk
pregnancy
benzodiazepines
hypnotics and sedatives
patient safety
Z-drugs

---
https://ansm.sante.fr/informations-de-securite/lamotrigine-lamictal-et-generiques-rappel-du-bon-usage-afin-de-limiter-le-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Lamotrigine
Lamotrigine
risk management
lamotrigine
anticonvulsants
anticonvulsants
stevens-johnson syndrome
drug eruptions
Drug-Related side effects and adverse reactions
epidermal necrolysis, toxic
drug hypersensitivity syndrome
adult
child
drug interactions

---
https://ansm.sante.fr/informations-de-securite/medicaments-a-base-de-mianserine-rappel-du-bon-usage-et-des-risques-deffets-indesirables-graves-notamment-chez-les-patients-ages
2023
false
false
false
France
French
mianserin
aged
risk
mianserin
pharmacovigilance note
guidelines for drug use
Off-Label use
sleep initiation and maintenance disorders
depressive disorder, major
antidepressive agents, second-generation

---
https://ansm.sante.fr/tableau-marr/glofitamab
2023
false
false
false
France
French
guidelines for drug use
risk management
antibodies, bispecific
antibodies, bispecific
glofitamab
glofitamab
patients guideline
Tumor Flare Reaction
signs and symptoms
continuity of patient care
Cytokine Release Syndrome
glofitamab

---
https://ansm.sante.fr/actualites/campagne-de-vaccination-contre-les-virus-hpv-lansm-deploie-un-dispositif-de-surveillance-renforcee
2023
false
false
false
France
French
drug information
mass vaccination
papillomavirus vaccines
france
papillomavirus infections
pharmacovigilance
product surveillance, postmarketing
papillomavirus vaccines

---
https://www.cbip.be/fr/articles/4168?folia=4158
2023
false
false
false
Belgium
French
pharmacovigilance note
journal article
clomiphene
selective estrogen receptor modulators
vision disorders
Clomiphene adverse reaction (disorder)
clomiphene

---
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1691503886633
2023
false
false
false
Canada
French
drug evaluation
Drug-Related side effects and adverse reactions
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
Antineoplastic Agents, Immunological
risk assessment
anemia, aplastic
Immune Checkpoint Inhibitors
canada
pharmacovigilance note

---
http://www.lecrat.eu/1778/
2023
false
false
false
France
French
drug information
valproic acid
paternal exposure
Neurodevelopmental Disorders
child
infant

---
https://ansm.sante.fr/actualites/les-vaccins-a-arnm-naugmentent-pas-le-risque-de-syndrome-de-guillain-barre-a-la-difference-des-vaccins-a-vecteur-adenoviral
2023
false
false
false
France
French
risk assessment
mRNA Vaccines
guillain-barre syndrome
drug evaluation
product surveillance, postmarketing
evaluation studies as topic
covid-19, RNA-based vaccine
COVID-19 Vaccines
COVID-19

---
https://ansm.sante.fr/actualites/encore-trop-de-grossesses-sous-carbamazepine-nous-souhaitons-renforcer-linformation-pour-limiter-lexposition
2023
false
false
false
France
French
pharmacovigilance note
pregnancy
carbamazepine
teratogens
abnormalities, drug-induced
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/epcoritamab
2023
false
false
false
France
French
risk management
bispecific monoclonal antibodies
Epcoritamab
patients guideline
Cytokine Release Syndrome
signs and symptoms
Immune Effector Cell Associated Neurotoxicity Syndrome
cell-associated neurotoxicity
drug information
epcoritamab

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-doctobre-2023-25-28-septembre
2023
false
false
false
France
French
pharmacovigilance note
product surveillance, postmarketing
Omacor
omega-3-triglycerides incl. other esters and acids
atrial fibrillation
omega-3 ethyl ester 90

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-novembre-2023-23-26-octobre
2023
false
false
false
France
French
drug information
risk assessment
thyroid neoplasms
glucagon-like peptide 1
hypoglycemic agents
GLP-1 Mimetics
Glucagon-like peptide-1 (GLP-1) analogues

---
https://www.cbip.be/fr/articles/4188?folia=4179
2023
false
false
false
Belgium
French
journal article
pharmacovigilance note
migraine disorders
Drug-Related side effects and adverse reactions
alopecia
Medicinal product acting as antimigraine agent (product)
Calcitonin gene-related peptide (CGRP) antagonists
calcitonin gene-related peptide
Calcitonin Gene-Related Peptide Receptor Antagonists

---
https://ansm.sante.fr/informations-de-securite/esters-ethyliques-dacides-omega-3-risque-accru-et-dose-dependant-de-fibrillation-auriculaire-ou-atriale-chez-des-patients-atteints-de-maladies-cardiovasculaires-ou-presentant-des-facteurs-de-risque-cardiovasculaires
2023
false
false
false
France
French
pharmacovigilance note
risk
Dose-dependent
atrial fibrillation
risk factors
fatty acids, Omega-3
Omega-3-Acid Ethyl Esters

---
https://ansm.sante.fr/actualites/antiepileptiques-et-grossesse-mieux-connaitre-les-risques-pour-lenfant-a-naitre
2023
false
false
false
France
French
technical report
popular works
drug information
anticonvulsants
risk
risk management
abnormalities, drug-induced
pregnancy
abnormalities, drug-induced
child
Neurodevelopmental Disorders

---
https://ansm.sante.fr/actualites/chlorhexidine-attention-au-risque-de-reaction-allergique-immediate-grave
2023
false
false
false
France
French
chlorhexidine
anti-infective agents, local
hypersensitivity, immediate
drug hypersensitivity
pharmacovigilance note

---
Nous contacter.
13/11/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.